Functionalized silica particles for gemcitabine delivery in cholangiocarcinoma
Frontiers in Cell and Developmental Biology · 20.11.2026 · 14
DOI: 10.3389/fcell.2026.1943322 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 20.11.2026. Verfasst von Kyrylo Baklan und 7 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Primary liver cancer (PLC) is the third leading cause of cancer-related mortality worldwide. Cholangiocarcinoma (CCA) is one of the main PLC types. Current CCA treatments are limited by low efficacy and severe side effects due to high systemic chemotherapy doses. Therefore, new targeted therapies are urgently needed. Spherical silica particles (SSPs) are promising nanocarriers owing to their uniform shape, favourable biocompatibility profile, and modifiable surface groups, enabling efficient drug loading. In this study, we evaluated the potential of gemcitabine (GEM)-loaded SSPs as a nanocarrier system for GEM delivery and anticancer activity in CCA cells in vitro . SSPs (148 nm ± 18 nm) were synthesized via a one-step method and functionalized with surface amino groups (2.2 mmol/g) and phenyl groups (1 mmol/g), allowing diverse interactions with GEM. The GEM adsorption capacity reached 6.5 mg/g, enabling efficient drug loading. Anticancer effects of GEM-loaded SSPs (SSPs + GEM) were tested in murine CCA cells, with CBA-310 fibroblasts as non-cancerous control. Cells were treated with SSPs + GEM at different drug concentrations, while controls included unloaded SSPs, free GEM, NaCl, and cell culture medium alone. Cytotoxicity was assessed via crystal violet staining assay and cell counting kit-8, apoptotic and necrotic cell populations via flow cytometry and senescence via senescence-associated β-galactosidase (SA-β-Gal) staining. SSPs + GEM significantly inhibited CCA cell growth at concentrations of 50, 100 and 200 μg/mL (corresponding to 1.2, 2.5 and 5 µM of GEM). The effects at the two highest concentrations showed comparable efficacy to 50 µM free GEM, that corresponds to the plasma concentration of GEM reported in patients. Furthermore, SSPs + GEM induced SA-β-Gal signal consistent with cellular senescence, as well as early and late apoptosis. Unloaded SSPs did not significantly affect the growth of either cell line up to 200 μg/mL, supporting low acute cytotoxicity under the tested in vitro conditions, although a transient increase in the early apoptotic signal was observed at the highest particle concentrations. In summary, functionalized SSPs represent a promising platform for GEM delivery in CCA, as demonstrated in vitro in a murine model. Translation into the clinical setting will require in vivo validation and confirmation in human CCA cells.
Zitieren
APA
Baklan, K., Kyshkarova, V., Potapenko, K., Petriv, N., Kaufhold, P., Wedemeyer, H., Melnyk, I., & Yevsa, T. (2026). Functionalized silica particles for gemcitabine delivery in cholangiocarcinoma. Frontiers in Cell and Developmental Biology, 14. https://doi.org/10.3389/fcell.2026.1943322
Vancouver
Baklan K, Kyshkarova V, Potapenko K, Petriv N, Kaufhold P, Wedemeyer H, et al. Functionalized silica particles for gemcitabine delivery in cholangiocarcinoma. Frontiers in Cell and Developmental Biology. 2026;14. doi:10.3389/fcell.2026.1943322
BibTeX
@article{Baklan2026,
author = {Baklan, Kyrylo and Kyshkarova, Viktoriia and Potapenko, Kateryna and Petriv, Nataliia and Kaufhold, Patrick and Wedemeyer, Heiner and Melnyk, Inna and Yevsa, Tetyana},
title = {Functionalized silica particles for gemcitabine delivery in cholangiocarcinoma},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
volume = {14},
doi = {10.3389/fcell.2026.1943322}
}
EUVIMED